-
1
-
2by Peter M. Prodinger, Peter Foehr, Dominik Bürklein, Oliver Bissinger, Hakan Pilge, Kilian Kreutzer, Rüdiger von Eisenhart-Rothe, Thomas TischerGet full text
Published 2018-02-01
Article -
3by Ingo J. Banke, Niko Stade, Peter M. Prodinger, Jutta Tübel, Alexander Hapfelmeier, Rüdiger von Eisenhart-Rothe, Martijn van Griensven, Hans Gollwitzer, Rainer BurgkartGet full text
Published 2020-08-01
Article -
4by Thomas G. P. Grunewald, Irene von Luettichau, Gregor Weirich, Angela Wawer, Uta Behrends, Peter M. Prodinger, Gernot Jundt, Stefan S. Bielack, Reiner Gradinger, Stefan BurdachGet full text
Published 2010-01-01
Article -
5by Sabine Stöckl, Georg Lindner, Shushan Li, Philipp Schuster, Sebastian Haferkamp, Ferdinand Wagner, Peter M. Prodinger, Gabriele Multhoff, Melanie Boxberg, Axel Hillmann, Richard J. Bauer, Susanne GrässelGet full text
Published 2020-10-01
Article -
6Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored doseby Stefanie Jilg, Richard T. Hauch, Johanna Kauschinger, Lars Buschhorn, Timo O. Odinius, Veronika Dill, Catharina Müller-Thomas, Tobias Herold, Peter M. Prodinger, Burkhard Schmidt, Dirk Hempel, Florian Bassermann, Christian Peschel, Katharina S. Götze, Ulrike Höckendorf, Torsten Haferlach, Philipp J. JostGet full text
Published 2019-04-01
Article